Sildenafil Telehealth Providers and Pricing

Direct answer

RightFit now tracks sildenafil programs from Hims, Ro, BlueChew, Henry Meds, and Mochi Health across manufactured tablets, compounded sublingual products, per-use pricing, dose-count monthly plans, and bundled care models. BlueChew adds a compounded sublingual format priced by tablet, while Hims and Ro publish different dose and plan structures. RightFit preserves the billing unit rather than forcing every offer into a monthly number.

Current sildenafil telehealth market snapshot

Henry Meds currently uses a bundled three-month program structure

Henry’s current ED program includes sildenafil options inside a three-month supply model. RightFit’s structured records include a sildenafil tablet product and a compounded sildenafil tablet product as separate formulations, each with the effective monthly amount attached to the three-month program rather than presented as unrestricted month-to-month billing.

The Henry records also identify clinician access and shipping as included in the tracked program. Those inclusions are stored separately from the product price so the commercial structure remains auditable.

Mochi separates the medication price from its membership

Mochi’s current sildenafil page publishes a medication starting price while requiring a separate Mochi membership. RightFit therefore does not present the medication amount as the full recurring program cost. The medication and membership remain separate commercial components.

The official sildenafil label establishes the approved drug context

Current official prescribing information identifies sildenafil tablets as a prescription drug indicated for erectile dysfunction. RightFit uses that regulator-primary source to establish the approved product context and keeps provider-specific compounded or commercial program details separate from the official label.

Manufactured and compounded records should not be merged

Henry’s current catalog includes a compounded sildenafil tablet alongside another sildenafil tablet record. A compounded formulation should not automatically inherit the same product identity or regulatory status as an approved manufactured tablet merely because both contain sildenafil. RightFit preserves preparation type when the source makes it clear.

Quantity and supply period belong beside the price

A sildenafil price is difficult to interpret without knowing how many units the provider supplies and over what period. Henry’s current program is structured around a three-month supply, while Mochi’s current record is modeled as a monthly medication price with a separate membership requirement. RightFit keeps those billing and supply differences visible.

A lower medication price can still have a separate recurring fee

The lowest medication-only number is not necessarily the lowest practical recurring program cost when a provider also requires a membership. Conversely, a higher-looking bundled amount may include clinician access or shipping. RightFit does not invent an all-in total unless every required component is verified.

Shipping and clinician access are commercial features

When a provider publishes that shipping or clinician access is included, RightFit records those features with the program. A provider page that does not disclose them remains unknown. Missing information is not treated as free service and is not used to make the program appear cheaper.

State availability needs its own evidence

A provider operating telehealth broadly does not prove that every sildenafil product is available in every state. RightFit publishes program-level state availability only when a current source supports it and otherwise leaves the field unverified.

What to compare across sildenafil programs

• Exact sildenafil formulation and provider product name.
• Preparation type when the provider identifies a compounded product.
• Published tablet strength and quantity as product-description fields.
• Supply duration and billing period.
• Normal or promotional price and any eligibility terms.
• Required membership or program fee.
• Whether clinician access and shipping are included.
• Program-specific state availability when verified.
• Provider-primary source and last-verification date.

What RightFit will not infer

• A higher tablet strength is not treated as better value.
• A lower medication price is not assumed to be the lowest total program cost.
• A compounded tablet is not automatically described as the same approved product as a manufactured tablet.
• The public program page does not determine an appropriate dose for an individual.
• A three-month effective monthly amount is not treated as true month-to-month billing.
• Provider availability is not assumed nationwide without program-level evidence.

Combination ED products need separate records

Some telehealth providers sell compounded products that combine sildenafil with another active ingredient. RightFit should not merge a combination product into the standalone sildenafil price table merely because sildenafil is one component. The ingredient combination, preparation type, and provider program need their own record.

Why price normalization needs care

A three-month bundled program can be divided into an effective monthly amount for comparison, but that calculation should not erase the actual commitment or supply period. RightFit keeps both the normalized amount and the underlying term visible when the provider source supports them.

Why source freshness matters

ED telehealth pricing can change through new membership terms, different supply quantities, revised tablet options, or promotional offers. RightFit favors current provider-owned treatment and program pages and keeps the verification date visible so an older price is not mistaken for a permanent market rate.

Questions a reader can use

• What exact product and formulation is being offered?
• How much supply is included in the quoted price?
• Is the amount billed monthly or for a longer term?
• Is there a separate membership?
• Are clinician review and shipping included?
• Is the product compounded?
• Does the provider publish state-specific availability?
• Is the price a standard rate or a conditional offer?
• When was the provider source last checked?

What this comparison cannot decide

A public provider comparison cannot determine whether sildenafil is appropriate for an individual, what strength or use pattern is appropriate, or how it interacts with other medications or health conditions. Those are clinical questions for a licensed healthcare professional. RightFit’s role is limited to transparent commercial and product information.

Bottom line

Current sildenafil telehealth programs now span Hims per-use pricing, Ro monthly dose-count plans, BlueChew compounded sublingual tablet pricing, Henry Meds bundled multi-month care, and Mochi medication pricing with a separate membership. RightFit keeps dose count, billing unit, preparation type, included services, and source date visible so per-tablet or per-use offers are not mistaken for monthly program totals.

Why unit count matters as much as the monthly equivalent

A monthly-looking sildenafil price can hide a multi-month supply and a specific tablet quantity. Henry’s current program is a good example: the effective monthly amount is derived from a longer bundled supply. Mochi uses a different structure with a medication price plus membership. RightFit keeps the supply and fee model beside the normalized price so the reader does not mistake two different purchase structures for identical monthly subscriptions.

Provider catalog changes should not erase product history

If a provider later changes the tablet quantity, formulation, membership requirement, or bundled services, RightFit should update the current record while preserving a real commercial change in price history when appropriate. Routine source re-verification without a material change should not create a false market movement.

A provider price does not establish pharmacy-wide cash pricing

Sildenafil is also available through pharmacy channels outside the telehealth programs tracked here. RightFit’s provider comparison therefore describes the verified telehealth commercial offer, not the universal cash price of sildenafil. The same drug name can appear at a different pharmacy price when clinician access, quantity, membership, or fulfillment are structured differently.

Product identity should stay more precise than the marketing category

The ED category can include standalone sildenafil, tadalafil, and compounded combination products. RightFit keeps those records separate so a low price from one product is not used to represent another. The treatment category helps navigation; the exact formulation remains the priceable unit.

Why telehealth price and pharmacy price are different comparisons

A telehealth sildenafil offer can include clinician review, fulfillment, shipping, and a membership or program structure that a standalone pharmacy cash price does not. RightFit therefore compares provider programs on their published commercial terms rather than implying that the telehealth amount is the universal market price of sildenafil. This keeps the provider comparison useful while avoiding a misleading conclusion that a lower tablet-only pharmacy quote and a bundled telehealth program are purchasing the same services.